Transcriptional regulation of inflammatory secreted phospholipases A(2).

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2000-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1388-1981(00)00117-7PMID 11080684
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein Kinase A–Dependent Stimulation of Rat Type II Secreted Phospholipase A2 Gene Transcription Involves C/EBP-&bgr; and -&dgr; in Vascular Smooth Muscle Cells

  2000cited by this paper
• Regulation of type V phospholipase A2 expression and function by proinflammatory stimuli.

  1999cited by this paper
• Functional Coupling Between Various Phospholipase A2s and Cyclooxygenases in Immediate and Delayed Prostanoid Biosynthetic Pathways*

  1999cited by this paper
• Gene activation by histone and factor acetyltransferases.

  1999cited by this paper
• Interleukin 1β Induces Type II-secreted Phospholipase A2 Gene in Vascular Smooth Muscle Cells by a Nuclear Factor κB and Peroxisome Proliferator-activated Receptor-mediated Process*

  1999cited by this paper
• The Beginning of the End: IκB Kinase (IKK) and NF-κB Activation*

  1999cited by this paper
• The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation.

  1999cited by this paper
• Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate*

  1999cited by this paper
• The Nuclear Factor-κB Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter*

  1999cited by this paper
• Nuclear Factor I (NFI) Isoforms Differentially Activate Simple versus Complex NFI-responsive Promoters*

  1998cited by this paper
• The Role of C/EBP Isoforms in the Control of Inflammatory and Native Immunity Functions*

  1998cited by this paper
• Roles of histone acetyltransferases and deacetylases in gene regulation

  1998cited by this paper
• Secretory phospholipase A2 and lipoprotein lipase enhance 15-lipoxygenase-induced enzymic and nonenzymic lipid peroxidation in low-density lipoproteins.

  1998cited by this paper
• Biological Role of the CCAAT/Enhancer-binding Protein Family of Transcription Factors*

  1998cited by this paper
• Cholesterol relieves the inhibitory effect of sphingomyelin on type II secretory phospholipase A2.

  1998cited by this paper
• Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced group II phospholipase A2 expression in rat renal mesangial cells.

  1998cited by this paper
• Ultrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteries.

  1998cited by this paper
• Cytosolic Phospholipase A2 Is Required for Cytokine-induced Expression of Type IIA Secretory Phospholipase A2 That Mediates Optimal Cyclooxygenase-2-dependent Delayed Prostaglandin E2 Generation in Rat 3Y1 Fibroblasts*

  1998cited by this paper
• An SP1-like 5'-GACCACGCC-3' sequence is critical for activity of the inflammatory phospholipase A2 promoter and binds several non-zinc finger proteins.

  1998cited by this paper
• The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome.

  1997cited by this paper
• CREB-binding protein/p300 are transcriptional coactivators of p65.

  1997cited by this paper
• p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha.

  1997cited by this paper
• Expression and subcellular distribution of the beta-isoform of the human glucocorticoid receptor.

  1997cited by this paper
• Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ

  1997cited by this paper
• Antioxidant-induced Nuclear Translocation of CCAAT/Enhancer-binding Protein β

  1997cited by this paper
• Modulation of human type II secretory phospholipase A2 by sphingomyelin and annexin VI.

  1997cited by this paper
• The Antidiabetic Agent Thiazolidinedione Stimulates the Interaction between PPARγ and CBP

  1997cited by this paper
• The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP.

  1997cited by this paper
• Expression and Subcellular Distribution of the β-Isoform of the Human Glucocorticoid Receptor.

  1997cited by this paper
• Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells.

  1997cited by this paper
• Suppression by cyclosporin A of interleukin 1β‐induced expression of group II phospholipase A2 in rat renal mesangial cells

  1997cited by this paper
• Cloning, Chromosomal Mapping, and Expression of a Novel Human Secretory Phospholipase A2 *

  1997cited by this paper
• Interaction and functional collaboration of p300 and C/EBPbeta

  1997cited by this paper
• Peroxisome proliferator-activated receptors, orphans with ligands and functions.

  1997cited by this paper
• Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.

  1997cited by this paper
• Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.

  1997cited by this paper
• C/EBP factor suppression of inhibition of type II secreted phospholipase A2 promoter in HepG2 cells: possible role of single-strand binding proteins

  1997cited by this paper
• p300 Functions as a Coactivator for the Peroxisome Proliferator-activated Receptor α*

  1997cited by this paper
• Effects of dexamethasone and transforming growth factor-beta 2 on group II phospholipase A2 mRNA and activity levels in interleukin 1 beta- and forskolin-stimulated mesangial cells.

  1996cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human.

  1996cited by this paper
• Secretory non-pancreatic phospholipase A2 and cyclooxygenase-2 expression by tracheobronchial smooth muscle cells.

  1996cited by this paper
• Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.

  1996cited by this paper
• Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells.

  1995cited by this paper
• Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily

  1995cited by this paper
• 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

  1995cited by this paper
• The Cytokine Responsive Vascular Smooth Muscle Cell Enhancer of Inducible Nitric Oxide Synthase

  1995cited by this paper
• Pyrrolidine dithiocarbamate differentially affects cytokine‐ and cAMP‐induced expression of group II phospholipase A2 in rat renal mesangial cells

  1995cited by this paper
• The Human 180-kDa Receptor for Secretory Phospholipases A2

  1995cited by this paper
• The nuclear receptor superfamily: the second decade.

  1995cited by this paper
• 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.

  1995cited by this paper
• Secretory group II phospholipase A2 in human atherosclerotic plaques.

  1995cited by this paper
• E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators.

  1994cited by this paper
• Transcription factors. CREB takes CBP to tango.

  1994cited by this paper
• The two ccaat-enhancer binding protein isoforms, IL-6DBP and C/EBP delta, are induced by interleukin-6 to promote gene transcription in hepatocytes via different mechanisms.

  1994cited by this paper
• CREB takes CBP to tango

  1994cited by this paper
• Insulin‐like growth factors counteract the effect of interleukin 1β on type II phospholipase A2 expression and arachidonic acid release by rabbit articular chondrocytes

  1994cited by this paper
• Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2.

  1994cited by this paper
• Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human platelets.

  1994cited by this paper
• Positive and negative hepatic regulation of the human type II phospholipase A2 gene.

  1994cited by this paper
• Group II phospholipase A2 in invasive gastric cancer cell line is induced by interleukin 6.

  1994cited by this paper
• Phosphorylated CREB binds specifically to the nuclear protein CBP

  1993cited by this paper
• Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.

  1993cited by this paper
• Cell-specific regulation of type II phospholipase A2 expression in rat mesangial cells.

  1993cited by this paper
• Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.

  1993cited by this paper
• Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6.

  1993cited by this paper
• Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response.

  1992cited by this paper
• Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes.

  1992cited by this paper
• Type II phospholipase A2 recombinant overexpression enhances stimulated arachidonic acid release.

  1991cited by this paper
• A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro.

  1991cited by this paper
• Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

  1991cited by this paper
• Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response.

  1991cited by this paper
• Interleukin‐1α stimulates the release of prostaglandin E2 and phospholipase A2 from fetal rat calvarial cells in vitro: Relationship to bone nodule formation

  1991cited by this paper
• Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression.

  1991cited by this paper
• Cyclic AMP mimics, but does not mediate, interleukin-1- and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat renal mesangial cells.

  1991cited by this paper
• Interleukin-1 alpha stimulates prostaglandin biosynthesis in serum-activated mesangial cells by induction of a non-pancreatic (type II) phospholipase A2.

  1991cited by this paper
• PDGF suppresses the activation of group II phospholipase A2 gene expression by interleukin I and forskolin in mesangial cells

  1991cited by this paper
• Cytokine- and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone.

  1991cited by this paper
• Amino‐terminal domain of NF1 binds to DNA as a dimer and activates adenovirus DNA replication.

  1990cited by this paper
• Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells

  1990cited by this paper
• A simple and sensitive method for determining transcription initiation site: identification of two transcription initiation sites in rat group II phospholipase A2 gene.

  1990cited by this paper
• A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.

  1990cited by this paper
• Structure and properties of a human non-pancreatic phospholipase A2.

  1989cited by this paper
• The proinflammatory effect of intra-articular injection of soluble human and venom phospholipase A2.

  1989cited by this paper
• Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

  1989cited by this paper
• Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid.

  1989cited by this paper
• Release of phospholipase A2 activity from rat vascular smooth muscle cells mediated by cAMP.

  1989cited by this paper
• Interleukin-1 beta stimulates phospholipase A2 mRNA synthesis in rabbit articular chondrocytes.

  1989cited by this paper
• Structural and functional organization of a porcine gene coding for nuclear factor I.

  1989cited by this paper
• Purification of a NF1‐like DNA‐binding protein from rat liver and cloning of the corresponding cDNA.

  1988cited by this paper
• A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs

  1988cited by this paper
• Multiple genes encode nuclear factor 1-like proteins that bind to the promoter for 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1988cited by this paper
• Pancreatic Phospholipase A2: Isolation of the Human Gene and cDNAs from Porcine Pancreas and Human Lung

  1986cited by this paper
• Classification of phospholipases A2 according to sequence. Evolutionary and pharmacological implications.

  1983cited by this paper

• Role of Arachidonic Acid and Its Metabolites in the Biological and Clinical Manifestations of Idiopathic Nephrotic Syndrome

  2021cites this paper
• A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis

  2021cites this paper
• Role of human group IIA secreted phospholipase A2 in malaria pathophysiology: Insights from a transgenic mouse model.

  2021cites this paper
• The inhibitory effect of saPLI&ggr;, a snake sourced PLA2 inhibitor on carrageenan‐induced inflammation in mice

  2018cites this paper
• Effects of Statins and Xuezhikang on the Expression of Secretory Phospholipase A2, Group IIA in Rat Vascular Smooth Muscle Cells.

  2017cites this paper
• Régulation des canaux ASIC par les lipides et la température – Conséquences sur les perceptions sensorielles et douloureuses

  2017cites this paper
• AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs

  2015cites this paper
• Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.

  2014cites this paper
• Statin Inhibits the Expression of Secretory Phospholipase A2 and Subsequent Monocyte Chemoattractant Protein-1 in Human Endothelial Cells

  2014cites this paper
• Etude du rôle de la phospholipase A2 sécrétée de type IIA dans la mucoviscidose : modulation de son expression par Pseudomonas aeruginosa

  2014cites this paper
• PLA 2 G 2 A ( phospholipase A 2 , group IIA ( platelets , synovial fluid ) )

  2012cites this paper
• PLA2G2A (phospholipase A2, group IIA (platelets, synovial fluid))

  2011cites this paper
• Differential contributions of protein kinase C isoforms in the regulation of group IIA secreted phospholipase A2 expression in cytokine-stimulated rat fibroblasts.

  2010cites this paper
• DIE INTERAKTION VON FORMYL-PEPTID-REZEPTOREN UND DEM SCAVENGER-REZEPTOR MARCO BEI DER SIGNALTRANSDUKTION VON AMYLOID-BETA 1-42 (Aß 1-42) IN

  2010cites this paper
• Phospholipases A2 and Inflammatory Responses in the Central Nervous System

  2010cites this paper
• Oxidative alterations induced in vitro by the photodynamic reaction in doxorubicin-sensitive (LoVo) and -resistant (LoVoDX) colon adenocarcinoma cells

  2010cites this paper
• Phospholipase A2 as a therapeutic target for atherosclerosis

  2010cites this paper
• Secretory phospholipase A2-IIA in Alzheimer's disease and inflammatory responses in astrocytes

  2009cites this paper
• Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes.

  2009cites this paper
• The anti-inflammatory pharmacology of Pycnogenol in humans involves COX-2 and 5-LOX mRNA expression in leukocytes.

  2009cites this paper
• C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.

  2009cites this paper
• Varespladib methyl, an oral phospholipase A2 inhibitor for the potential treatment of coronary artery disease.

  2009cites this paper
• Secretory Phospholipase A2, Group IIA Is a Novel Serum Amyloid A Target Gene

  2009cites this paper
• Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis.

  2009cites this paper
• C/EBP (cid:1) is required for pulmonary cytoprotection during hyperoxia

  2009cites this paper
• Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.

  2008cites this paper
• Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage

  2008cites this paper
• Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms.

  2008cites this paper
• On interaction of activated protein C with human aortic smooth muscle cells attenuating the secretory group IIA phospholipase A2 expression.

  2008cites this paper
• The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.

  2008cites this paper
• Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFα‐stimulated human endothelial cells

  2008cites this paper
• Étude des mécanismes athérogènes associés à l'insulino-résistance et l'hypercholestérolémie familiale

  2008cites this paper
• This information is current as Biosynthetic Pathway 2 Prostaglandin E Evidence for Divergent Influence on the Expression in Human Orbital Fibroblasts : Prostaglandin Endoperoxide H Synthase 2 of β Jak 2 Dampens the Induction by IL-1

  2007cites this paper
• This information is current as Biosynthetic Pathway 2 Prostaglandin E Evidence for Divergent Influence on the Expression in Human Orbital Fibroblasts : Prostaglandin Endoperoxide H Synthase 2 of β Jak 2 Dampens the Induction by IL-1

  2007cites this paper
• Jak2 Dampens the Induction by IL-1β of Prostaglandin Endoperoxide H Synthase 2 Expression in Human Orbital Fibroblasts: Evidence for Divergent Influence on the Prostaglandin E2 Biosynthetic Pathway1

  2007cites this paper
• Edema Toxin Impairs Anthracidal Phospholipase A2 Expression by Alveolar Macrophages

  2007cites this paper
• Cyclooxygenase‐1 and ‐2 enzymes differentially regulate the brain upstream NF‐κB pathway and downstream enzymes involved in prostaglandin biosynthesis

  2006cites this paper
• Secreted phospholipase A2 inhibitors are also potent blockers of binding to the M-type receptor.

  2006cites this paper
• Activation of sPLA2‐IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL‐1β

  2006cites this paper
• Interferon γ-Induced Gene Expression of the Novel Secretory Phospholipase A2 Type IID in Human Monocyte-Derived Macrophages is Inhibited by Lipopolysaccharide

  2006cites this paper
• Search of Factors That Intermediate Cytokine-induced Group IIA Phospholipase A2 Expression through the Cytosolic Phospholipase A2- and 12/15-Lipoxygenase-dependent Pathway*

  2005cites this paper
• Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.

  2005cites this paper
• Role of nitric oxide in regulating secreted phospholipase A2 release from astrocytes

  2005influential citation
• Autocrine and Paracrine Transcriptional Regulation of Type IIA Secretory Phospholipase A2 Gene in Vascular Smooth Muscle Cells

  2005cites this paper
• Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells

  2005cites this paper
• A 2 Gene in Vascular Smooth Muscle Cells Autocrine and Paracrine Transcriptional Regulation of Type IIA Secretory Phospholipase

  2005cites this paper
• Transcriptional regulation of genes for enzymes of the prostaglandin biosynthetic pathway.

  2004cites this paper
• A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription.

  2004cites this paper
• Gene expression analysis to identify mRNA markers of cardiac myxoma.

  2004cites this paper
• Phospholipase A2 and remodeling in inflammatory cells

  2004cites this paper
• Ceramide-induced enhancement of secretory phospholipase A2 expression via generation of reactive oxygen species in tumor necrosis factor-alpha-stimulated mesangial cells.

  2004cites this paper
• Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro.

  2004cites this paper
• Glycogen synthase kinase‐3β negatively regulates group IIA phospholipase A2 expression in human aortic smooth muscle and HepG2 hepatoma cells

  2004cites this paper
• Prostaglandin E2 as a mediator of fever: synthesis and catabolism.

  2004cites this paper
• Phospholipase A2 isozymes in pregnancy and parturition.

  2004cites this paper
• Phospholipase A2 in the pathogenesis of cardiovascular disease

  2003cites this paper
• Phospholipase A2 expression in tumours: a target for therapeutic intervention?

  2003cites this paper
• Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase‐2 in astrocytes: Synergy with interleukin‐1β, tumor necrosis factor‐α, and bacterial lipopolysaccharide

  2003cites this paper
• Augmented PLA2 activity in pre-eclamptic decidual tissue--a key player in the pathophysiology of 'acute atherosis' in pre-eclampsia?

  2003cites this paper
• Pertussis toxin-sensitive secretory phospholipase A2 expression and motility in activated primary human keratinocytes.

  2003cites this paper
• Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation

  2003cites this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

  2002cites this paper
• Microgli aan dInflammatory Mechanism si nth eClearance o fAmyloi d Peptide

  2002cites this paper
• Design of a chimeric promoter induced by pro‐inflammatory mediators in articular chondrocytes

  2002cites this paper
• Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide.

  2002cites this paper
• Effects of anti-arthritis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes.

  2002cites this paper
• Protein regulators of eicosanoid synthesis: role in inflammation.

  2002cites this paper
• Long-term modulation of glucose utilization by IL-1 alpha and TNF-alpha in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms.

  2002cites this paper
• Long‐term modulation of glucose utilization by IL‐1α and TNF‐α in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms

  2002cites this paper
• Prostaglandin E(2)-synthesizing enzymes in fever: differential transcriptional regulation.

  2002cites this paper
• Phospholipase A(2) in vascular disease.

  2001cites this paper
• p38 MAPK Regulates Group IIa Phospholipase A2Expression in Interleukin-1β-stimulated Rat Neonatal Cardiomyocytes*

  2001cites this paper